Chinese Biotech Firm Plans To Mass Produce Ebola Vaccine A Chinese company had expressed intentions of building a facility for mass production of Ebola vaccines. The exact date of operation has not been released but the manufacturing facility is expected to be completed by 2017 or 2018. by Rina Marie Doctor
Chatbots Could Be Suffering from Confirmation Bias When Tackling Controversial Issues: John Hopkins Study